Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ruppert

Showing results (101-110 of 188) with videos related to

Pageof 19
Sort By:
Haematologica|May 17, 2020
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemiaNyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, et al.
Bone Marrow Transplantation|April 16, 2013
Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphomaJ B Cohen, N C Hall, A S Ruppert, et al.
International Journal of Oncology|June 18, 2004
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B studySherif S Farag, Amy S Ruppert, Krzysztof Mrózek, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphomaJonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Clinical Breast Cancer|July 7, 2011
Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancerMaryam B Lustberg, Stephen P Povoski, Weiqiang Zhao, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
Leukemia|May 25, 2011
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridolK A Blum, A S Ruppert, J A Woyach, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2009
A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumorsBhuvaneswari Ramaswamy, Tanios Bekaii-Saab, Larry J Schaaf, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Pageof 19

Showing results (101-110 of 188) with videos related to

Sort By:
Pageof 19
Haematologica|May 17, 2020
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemiaNyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, et al.
Bone Marrow Transplantation|April 16, 2013
Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphomaJ B Cohen, N C Hall, A S Ruppert, et al.
International Journal of Oncology|June 18, 2004
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B studySherif S Farag, Amy S Ruppert, Krzysztof Mrózek, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphomaJonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Clinical Breast Cancer|July 7, 2011
Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancerMaryam B Lustberg, Stephen P Povoski, Weiqiang Zhao, et al.
Blood|May 4, 2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B studyMichael D Radmacher, Guido Marcucci, Amy S Ruppert, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2015
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemiaVeronica Balatti, Lara Rizzotto, Cecelia Miller, et al.
Leukemia|May 25, 2011
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridolK A Blum, A S Ruppert, J A Woyach, et al.
Cancer Chemotherapy and Pharmacology|September 24, 2009
A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumorsBhuvaneswari Ramaswamy, Tanios Bekaii-Saab, Larry J Schaaf, et al.
Blood|January 15, 2008
Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calciumSyed-Rehan A Hussain, David M Lucas, Amy J Johnson, et al.
Pageof 19